These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34983730)

  • 21. Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research.
    Feng X; Li Y; Gao W
    Joint Bone Spine; 2015 Dec; 82(6):428-31. PubMed ID: 26456042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
    Janssen CA; Jansen TLTA; Oude Voshaar MAH; Vonkeman HE; van de Laar MAFJ
    Rheumatol Int; 2017 Sep; 37(9):1435-1440. PubMed ID: 28748426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials.
    Zhang X; Tang Y; Wang M; Wang D; Li Q
    Clin Rheumatol; 2021 Feb; 40(2):701-710. PubMed ID: 32562072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol.
    Day RO; Frensham LJ; Nguyen AD; Baysari MT; Aung E; Lau AYS; Zwar N; Reath J; Laba T; Li L; McLachlan A; Runciman WB; Buchbinder R; Clay-Williams R; Coiera E; Braithwaite J; McNeil HP; Hunter DJ; Pile KD; Portek I; WIlliams KM; Westbrook JI
    BMJ Open; 2017 Oct; 7(10):e017281. PubMed ID: 29042386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gout management: an update].
    Ankli B; Krähenbühl S
    Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound in gout: a useful tool for following urate-lowering therapy.
    Ottaviani S; Gill G; Aubrun A; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2015 Jan; 82(1):42-4. PubMed ID: 25543275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study.
    Jatuworapruk K; Grainger R; Dalbeth N; Taylor WJ
    Int J Rheum Dis; 2022 Feb; 25(2):154-162. PubMed ID: 34796661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study.
    Ebstein E; Forien M; Norkuviene E; Richette P; Mouterde G; Daien C; Ea HK; Brière C; Lioté F; Petraitis M; Bardin T; Ora J; Dieudé P; Ottaviani S
    Rheumatology (Oxford); 2019 Mar; 58(3):410-417. PubMed ID: 30285127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lowering Serum Urate With Urate-Lowering Therapy to Target and Incident Fracture Among People With Gout.
    Wei J; Choi HK; Dalbeth N; Lane NE; Wu J; Lyu H; Zeng C; Lei G; Zhang Y
    Arthritis Rheumatol; 2023 Aug; 75(8):1456-1465. PubMed ID: 36940260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis.
    Kampe RT; Nielsen SM; Hotea I; van Durme C; Christensen R; Boonen A
    Semin Arthritis Rheum; 2022 Oct; 56():152049. PubMed ID: 35728446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016.
    Tsoi MF; Chung MH; Cheung BMY; Lau CS; Cheung TT
    Arthritis Res Ther; 2020 Sep; 22(1):204. PubMed ID: 32887668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
    Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
    Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study.
    Kim A; Kim Y; Kim GT; Ahn E; So MW; Lee SG
    Clin Rheumatol; 2020 Dec; 39(12):3769-3776. PubMed ID: 32458236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal evolution of urate crystal deposition over articular cartilage after successful urate-lowering therapy in patients with gout: An ultrasonographic perspective.
    Das S; Goswami RP; Ghosh A; Ghosh P; Lahiri D; Basu K
    Mod Rheumatol; 2017 May; 27(3):518-523. PubMed ID: 27492663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.
    Beslon V; Moreau P; Maruani A; Maisonneuve H; Giraudeau B; Fournier JP
    J Gen Intern Med; 2018 Mar; 33(3):358-366. PubMed ID: 29204974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia.
    Bavanendrakumar M; Robinson PC
    Intern Med J; 2020 Mar; 50(3):337-341. PubMed ID: 31386267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achievement of the target serum urate level among patients with gout treated with allopurinol or febuxostat in an arthritis clinic in the Philippines.
    Quilisadio JEC; Salido EO; Penserga EG
    Mod Rheumatol; 2021 May; 31(3):755-761. PubMed ID: 32701037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with initiation and persistence of urate-lowering therapy.
    Dehlin M; Ekström EH; Petzold M; Strömberg U; Telg G; Jacobsson LT
    Arthritis Res Ther; 2017 Jan; 19(1):6. PubMed ID: 28095891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.